Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1987-11-13
1989-02-28
Berch, Mark L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
540363, C07D41712, A61K 31425
Patent
active
048085790
ABSTRACT:
The disclosure describes (S)-3-[2-(2-amino-4-thiazolyl)]-(Z)-2-methoxyiminoacetylamino-2-oxo-1-azet idinyliminoacetic acid and (S)-3-[2-(2-amino-4-thiazolyl)]-(Z)-2-methoxyiminoacetylamino-2-(S)-methyl -4-oxo-1-azetidinyliminoacetic acid and the cationic salts thereof which possess antibacterial activity.
REFERENCES:
patent: 4723002 (1988-02-01), Bisacchi
Curran William V.
Lenhard Robert H.
American Cyanamid Company
Berch Mark L.
Conroy, Jr. Edward A.
LandOfFree
Novel monocycle .beta.-lactam antibacterials does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel monocycle .beta.-lactam antibacterials, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel monocycle .beta.-lactam antibacterials will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1367122